Hospital Universitario Severo Ochoa

Futó vizsgálatok

• Még nem toboroz

  Safety and Efficacy Comparison Between CHF5993 100/6 12.5µg pMDI to Seretide Evohaler 125/25µg pMDI in Adolescent Subjects With Asthma

  NCT07858123· 3. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Toboroz

  Heart Failure in Women: Epidemiological and Prognostic Insights

  NCT07847983· Carolina Ortiz Cortes· Forrás

• Még nem toboroz

  Optimizing the Use of Aspirin for the Prevention of Preeclampsia

  NCT07665853· 3. fázis· Hospital Universitari Vall d'Hebron Research Institute· Forrás

• Toboroz

  A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1)

  2025-524040-35-00· 3. fázis· Generate Biomedicines Inc.· Forrás

• Toboroz

  Grass Immunotherapy for Rhinitis and Asthma (GIRA)

  2025-521736-10-00· 3. fázis· LETI Pharma S.L.U.· Forrás

• Toboroz

  Grass/Olive Immunotherapy for Rhinitis and Asthma (GOES)

  2025-521709-42-00· 3. fázis· LETI Pharma S.L.U.· Forrás

• Még nem toboroz

  Treatment for Ph-negative ALL for Adults up to 65 Years

  NCT07443592· PETHEMA Foundation· Forrás

• Még nem toboroz

  Phase 1b/2 Trial of OMTX705, an Anti-Fibroblast Activation Protein Antibody-Drug Conjugate, in Combination with Carboplatin, Pemetrexed and Tislelizumab in Patients with Advanced/Metastatic Non-squamous Non-Small Cell Lung Cancer

  2025-521989-95-00· 1/2. fázis· Oncomatryx Biopharma S.L.· Forrás

• Toboroz

  PALACE: Cemiplimab Trial According to ctDNA Levels

  NCT06917573· 2. fázis· Fundación GECP· Forrás

• Toboroz

  Non-Steroidal Anti-Inflammatory Drugs in Acute Myocarditis

  NCT06686862· 3. fázis· Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III· Forrás

• Toboroz

  Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function

  NCT06943469· Société des Produits Nestlé (SPN)· Forrás

• Toboroz

  Advanced Invasive Diagnosis Strategy for Post-PCI Patients With Stable Coronary Syndromes Undergoing Coronary Angiography

  NCT07638137· Fundacion Investigacion Interhospitalaria Cardiovascular· Forrás

• Toboroz

  Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.

  NCT06724159· Spanish Oncology Genito-Urinary Group· Forrás

• Fut, nem toboroz

  Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine

  NCT06543914· AbbVie· Forrás

• Toboroz

  A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  NCT06345729· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.

  NCT05930275· AbbVie· Forrás

• Fut, nem toboroz

  Study which tests 2 medications (SB27, Keytruda) to compare how effective, safe and well tolerated in a large number of metastatic non-squamous non-small cell lung cancer patients

  2023-507448-36-00· 3. fázis· Samsung Bioepis Co. Ltd.· Forrás

• Toboroz

  Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

  NCT05398094· 2. fázis· Fundación GECP· Forrás

• Fut, nem toboroz

  Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy: (REMOVE)

  2023-504946-70-00· 4. fázis· Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia· Forrás

• Fut, nem toboroz

  Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)

  NCT04675333· 2. fázis· ALX Oncology Inc.· Forrás

• Fut, nem toboroz

  Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)

  NCT04675294· 2. fázis· ALX Oncology Inc.· Forrás

• Fut, nem toboroz

  Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

  NCT04595565· 3. fázis· GBG Forschungs GmbH· Forrás

• Toboroz

  A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)

  NCT02819882· Spanish Breast Cancer Research Group· Forrás

• Fut, nem toboroz

  A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

  NCT02130362· AbbVie· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Asztma4 toboroz
• Tüdőrák3 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Áttétes emlőrák1 toboroz
• Hólyagrák1 toboroz
• Koszorúér-betegség1 toboroz
• Myocarditis1 toboroz
• Prosztatarák1 toboroz
• Szarkóma1 toboroz
• Szívelégtelenség1 toboroz
• Vesedaganat1 toboroz

Lezárt vizsgálatok

• Lezárult

  Real World Evidence of Tivozanib as First-line Treatment for Metastatic Clear Cell Renal Cell Carcinoma

  NCT07354282· Spanish Oncology Genito-Urinary Group· Forrás

• Toboroz

  A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients

  NCT06578078· 3. fázis· Fundación para la Investigación del Hospital Clínico de Valencia· Forrás

• Lezárult

  Study which tests 3 medicines (SB27, EU sourced Keytruda, and US sourced Keytruda) in early or locally advanced non-small cell lung cancer patients who underwent surgery and adjuvant chemotherapy

  2023-507438-25-00· 1. fázis· Samsung Bioepis Co. Ltd.· Forrás

• Lezárult

  Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)

  NCT04776447· 2. fázis· Fundación GECP· Forrás

• Lezárult

  Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia

  NCT04864795· Vifor (International) Inc.· Forrás

• Lezárult

  Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

  NCT03982394· AbbVie· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Immune thrombocytopenia (ITP)4 munka · 0 vizsgálat